Developer docs
API playgroundTry for free, no card

Search company profiles

Floreo

Full company profile

uuid0000r3b

Namestring
Floreo
Legal namestring
Floreo, Inc.
Websiteurl
floreovr.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Floreo is a privately held, Delaware-incorporated virtual reality behavioral therapy company founded in 2016 by Vijay Ravindran and headquartered in Chevy Chase, Maryland. It develops research-based VR simulations that allow neurodiverse individuals — primarily those with Autism Spectrum Disorder, ADHD, and anxiety — to practice social, communication, behavioral regulation, daily living, and job skills in safe, repeatable virtual environments. The platform supports Meta Quest 2/3/Pro, PICO enterprise headsets, and a smartphone/Google Cardboard browser mode, with telehealth-ready remote delivery. Its clinical content is built by an in-house team of BCBAs, a CCC-SLP with 30+ years of experience, and an MD clinical consultant specializing in neurodevelopmental disabilities.

The product portfolio centers on the Floreo VR Platform with audience-specific modules for Providers, Education, and Families. FloreoRx is the company's FDA-regulated therapeutic software product, supported by a 125-patient pivotal trial across 18 Cortica Healthcare sites demonstrating a 45.6% responder rate versus 23.3% in a VR control group, 95.1% skill mastery, and sustained improvements at 60-day follow-up; a De Novo FDA request was submitted in April 2026 following Breakthrough Device designation and TAP Program acceptance in December 2023. The portfolio was expanded in April 2024 with the acquisition of Autism Eyes (a Cleveland Clinic Innovations portfolio company in autism diagnostics), and in October 2025 with the Digital Boundaries online-safety simulation series developed with the Cuyahoga County Board of Developmental Disabilities. The platform integrates generative AI characters powered by OpenAI for conversational practice.

Floreo monetizes via subscription licensing to families, schools, and enterprise providers; state Medicaid waiver reimbursement in Wisconsin, Tennessee, New York, Maryland, and Washington DC; bundled VR headset equipment rental; direct enterprise and government contracts (e.g., Tennessee DIDD two-year pilot); and CPT III Code 0770T for clinical VR therapy billing. Distribution runs through direct enterprise sales, the floreovr.com storefront, the Meta Quest Store, and the PICO Business Store. To date, Floreo has raised approximately $12.1M in venture funding across a 2017 seed, an October 2022 $10M Series A led by Tenfore Holdings, and a small July 2025 round; Cleveland Clinic joined as a strategic investor and board observer in April 2024.

Short descriptiontext

Floreo develops FDA-designated virtual reality therapy software that delivers immersive social, communication, and behavioral skills training to neurodiverse individuals (autism, ADHD, anxiety), serving healthcare providers, K-12 schools, state disability agencies, and families via subscription, Medicaid waiver, and CPT III billing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersChevy Chase, United States
HQ citystring
Chevy Chase
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
virtual reality therapy, autism behavioral therapy, digital therapeutics, neurodiverse skill training, social skills VR platform
Industry1 code
PRIMARYEDAKAHAL
Telehealth/Remote ABA & Digital Behavior Coaching
Education/Special Education & Learning Support Services/Behavioral Intervention & Applied Behavior Analysis (ABA)
NAICS code1 code
  • Services for the Elderly and Persons with Disabilities624120
Product category
Virtual Reality Behavioral Therapy Software
Social media profiles3 records
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1Subscription Licensing
TypeSubscription Recurring
Description

Recurring subscription model for access to VR lesson library and platform features. Subscriptions available for families, schools, and enterprise/organizational accounts. Pricing varies by account type and user count.

floreovr.com
2State Waiver Reimbursement
TypeSubscription Recurring
Description

Floreo subscriptions eligible for reimbursement through state Medicaid waiver programs including Wisconsin (Children's Long Term Support waiver), Tennessee (MAPS program), New York (OPWDD Self Directed Services Waiver), Maryland, and Washington DC. Equipment rental also covered under some waivers.

floreovr.com
3Equipment Rental
TypeHardware Sales
Description

VR headset rental bundled with subscriptions for families, particularly through state waiver programs. Provides complete solution including hardware and software.

floreovr.com
4CPT III Code 0770T
TypeProfessional Services
Description

Floreo sponsored the application for CPT III Code 0770T representing practice expense for VR technology software, enabling clinics to report VR technology use per session for therapy billing.

floreovr.com
5Enterprise/Government Contracts
TypeSubscription Recurring
Description

Direct contracts with state government agencies (Tennessee DIDD), county boards of developmental disabilities, and school districts for deployment of VR therapy programs.

floreovr.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details4 tiers
1Enterprise/organizational subscription for providers, schools, and institutions
ModelSubscriptionBilling cadenceAnnual
Notes

Organizational accounts with multiple learner seats; pricing varies based on user count and organization type

floreovr.com
2Floreo Classroom Bundle for schools
ModelSubscriptionBilling cadenceAnnual
Notes

Classroom Bundle available for $250 through 2023/2024 school year in collaboration with Meta for Immersive Learning Program

floreovr.com
3Family/home subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Direct consumer subscription potentially covered by Medicaid waivers in Wisconsin, New York, Tennessee, Maryland, and Washington DC

floreovr.com
4Equipment rental with subscription
ModelUnit PricingBilling cadenceMonthly
Notes

VR headset rental (Meta Quest) bundled with subscription; fully covered under some state waiver programs

floreovr.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

Floreo provides a research-based virtual reality behavioral therapy platform that enables neurodiverse individuals (primarily those with autism, ADHD, and anxiety) to practice social, communication, behavioral regulation, daily living, and independent living skills through immersive VR simulations. The platform is offered as audience-tailored subscriptions: Floreo for Providers (clinics and therapy practices), Floreo for Education (K-12 schools and districts), and Floreo for Families (home use), with optional bundled VR headset rental and telehealth-ready remote delivery. A separate regulated product, FloreoRx, is pursuing FDA De Novo authorization as a therapeutic device for ASD social communication skills.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 45.6% responder rate vs 23.3% VR control in pivotal trial; 95.1% skill mastery rate; sustained improvements at 60-day follow-up; no serious adverse events
Product overview1 text field

Floreo is a virtual reality behavioral therapy platform consisting of a core VR software product supplemented by audience-specific modules. The core Floreo VR Platform delivers immersive social and behavioral skills training through VR simulations accessible via smartphone/Cardboard, Meta Quest, and PICO headsets. Enterprise variants include Floreo for Providers (clinics/therapists), Floreo for Education (schools), and Floreo for Families (home use). FloreoRx represents the company's FDA-regulated therapeutic device pathway targeting ASD social communication skills. The portfolio was expanded through the 2024 acquisition of Autism Eyes (autism diagnostics from Cleveland Clinic) and the Digital Boundaries content series (online safety training). The platform incorporates AI characters powered by OpenAI for interactive conversational experiences.

Product and service6 records
1Floreo for Providers
CategoryEnterprise Therapy Platform
Description

Enterprise VR subscription for healthcare providers (clinics, therapy practices, ABA therapy organizations) enabling clinicians to deliver VR-based behavioral therapy sessions with progress tracking, reporting, telehealth-ready delivery, and support for CPT III Code 0770T billing.

2Floreo for Education
CategoryEducational Platform
Description

K-12 education subscription enabling schools, charter schools, and districts to use Floreo VR lessons for social skills instruction, classroom accommodations, special education programming, executive functioning skill development, and transition planning, with FERPA-compliant school official framework.

3Floreo for Families
CategoryConsumer Subscription
Description

Direct-to-consumer monthly home subscription for parents and caregivers of neurodiverse children and adults, enabling home-based VR therapy practice, skill reinforcement, and family coaching with COPPA compliance and optional Meta Quest headset rental.

4FloreoRx
CategoryRegulated Digital Therapeutic
Description

FDA-regulated VR-based therapeutic software (De Novo pending) designed to support skill development in individuals with Autism Spectrum Disorder; if authorized, would be one of the first FDA-authorized therapeutic devices for core social communication challenges associated with ASD.

5Digital Boundaries
CategorySpecialty Lesson Series
Description

Series of VR simulations focused on online safety skills for neurodivergent youth and adults, developed in partnership with Cuyahoga County Board of Developmental Disabilities and designed to be rolled out across Cleveland and nationwide.

6Autism Eyes
CategoryAutism Diagnostics
Description

Acquired autism diagnostics product from Cleveland Clinic Innovations providing accelerated and objective assessment of autism risk to streamline diagnosis and potentially improve patient outcomes; expanded Floreo into the autism diagnostics space.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

Partnership to create Digital Boundaries online safety training program for neurodivergent youth and adults, to be rolled out across Cleveland and nationwide.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-04
Description

Acquired Autism Eyes, a Cleveland Clinic Innovations portfolio company focused on autism diagnostics, expanding Floreo into diagnostics space. Cleveland Clinic also made a strategic investment in Floreo and joined its board as an observer.

3PICO Business Store (ByteDance)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-03-21
Description

Floreo available in PICO Business Store for enterprise PICO headset users (Neo3, Neo3 Pro/Pro Eye, PICO 4E, PICO 4 Ultra).

floreovr.com
4Tennessee Department of Intellectual and Developmental Disabilities
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-16
Description

Two-year contract for VR pilot project developing transportation and job skills curriculum for people with intellectual and developmental disabilities.

floreovr.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Conducted pivotal clinical trial for FloreoRx FDA submission across 18 clinical sites with 125 enrolled patients demonstrating statistically significant improvements.

Strategic tierCoreTypeTechnology or Integration
Description

Collaboration with Meta for Immersive Learning Program providing free Meta Quest 2 headsets to schools; Floreo available on Meta Quest store.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Workforce development program using Floreo with neurodiverse students; Easterseals received Meta Quest headsets through Immersive Learning Program.

8The School District of Palm Beach County
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Florida school district signed up to implement Floreo program for neurodiverse students.

floreovr.com
9Wattle Supports PTY LTD
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Australia-based partner signed up to begin Floreo program serving neurodiverse clients and community.

floreovr.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AppliedVR develops FDA-authorized VR therapeutic software (EaseVRx for chronic pain) and is expanding into mental health and behavioral indications. Like Floreo, it pursues the FDA digital therapeutics regulatory pathway and distributes via consumer VR hardware, making it a closely comparable regulatory and commercial peer.

2XRHealth
TypeDirect peer
Description

XRHealth operates a VR-based telehealth platform delivering clinician-supervised therapeutic experiences across mental health, neurological, and physical conditions. It directly parallels Floreo's VR telehealth delivery model, multi-condition content library, and provider/clinic GTM motion.

TypeDirect peer
Description

BehaVR builds immersive VR therapeutics for mental health (anxiety, depression, chronic pain) and partners with payers and providers on prescription digital therapeutics. Like Floreo, it combines clinical evidence generation with multi-headset distribution and a regulatory-grade development approach.

TypeDirect peer
Description

PresenceLearning provides live, online tele-ABA and related special education services to schools and districts nationwide. It overlaps directly with Floreo's behavioral intervention + telehealth delivery focus on the school-district and provider buyer, addressing a similar neurodiverse learner base.

TypeBroad incumbent
Description

CentralReach is an established practice management and clinical platform serving ABA and behavioral health providers at scale. It represents the incumbent software stack that Floreo providers may already use, making it a competitor for clinician wallet share and a potential integration or competitive threat to Floreo's clinical workflow layer.

TypeBroad incumbent
Description

Rethink provides digital tools, training, and consulting for ABA providers, educators, and employers serving individuals with autism and IDD. It is a broader incumbent in the same behavioral intervention space Floreo targets, with overlapping school and provider buyers.

TypeEmerging player
Description

Cognivive develops VR-based cognitive and behavioral therapy experiences, including attention and executive function training. It is an emerging peer focused on a narrower cognitive therapy niche within the same VR-based behavioral intervention category Floreo occupies.

TypeEmerging player
Description

Limbic builds AI-driven mental health support tools (including AI therapy companions) used by healthcare providers. While not VR-based, its focus on AI-augmented behavioral therapy delivery for clinical populations makes it thematically comparable to Floreo's generative AI character work in VR lessons.

TypeOthers
Description

HopSkipDrive is a specialized ride service for vulnerable populations including children with special needs, frequently reimbursed through Medicaid waivers in multiple states. It is a relevant peer in the special-needs Medicaid waiver ecosystem where Floreo also distributes subscriptions to families.

TypeOthers
Description

Cleveland Clinic Innovations is the corporate venture arm of Cleveland Clinic and was a prior owner of Autism Eyes, now acquired by Floreo. Cleveland Clinic also made a strategic investment in Floreo and holds a board observer seat — making it both a transaction counterparty and a strategic backer in the neurodiverse care space Floreo operates in.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Floreo

Virtual Reality Behavioral Therapy Softwarefloreovr.com

Floreo develops FDA-designated virtual reality therapy software that delivers immersive social, communication, and behavioral skills training to neurodiverse individuals (autism, ADHD, anxiety), serving healthcare providers, K-12 schools, state disability agencies, and families via subscription, Medicaid waiver, and CPT III billing.

What Floreo does

Floreo is a privately held, Delaware-incorporated virtual reality behavioral therapy company founded in 2016 by Vijay Ravindran and headquartered in Chevy Chase, Maryland. It develops research-based VR simulations that allow neurodiverse individuals — primarily those with Autism Spectrum Disorder, ADHD, and anxiety — to practice social, communication, behavioral regulation, daily living, and job skills in safe, repeatable virtual environments. The platform supports Meta Quest 2/3/Pro, PICO enterprise headsets, and a smartphone/Google Cardboard browser mode, with telehealth-ready remote delivery. Its clinical content is built by an in-house team of BCBAs, a CCC-SLP with 30+ years of experience, and an MD clinical consultant specializing in neurodevelopmental disabilities.

The product portfolio centers on the Floreo VR Platform with audience-specific modules for Providers, Education, and Families. FloreoRx is the company's FDA-regulated therapeutic software product, supported by a 125-patient pivotal trial across 18 Cortica Healthcare sites demonstrating a 45.6% responder rate versus 23.3% in a VR control group, 95.1% skill mastery, and sustained improvements at 60-day follow-up; a De Novo FDA request was submitted in April 2026 following Breakthrough Device designation and TAP Program acceptance in December 2023. The portfolio was expanded in April 2024 with the acquisition of Autism Eyes (a Cleveland Clinic Innovations portfolio company in autism diagnostics), and in October 2025 with the Digital Boundaries online-safety simulation series developed with the Cuyahoga County Board of Developmental Disabilities. The platform integrates generative AI characters powered by OpenAI for conversational practice.

Floreo monetizes via subscription licensing to families, schools, and enterprise providers; state Medicaid waiver reimbursement in Wisconsin, Tennessee, New York, Maryland, and Washington DC; bundled VR headset equipment rental; direct enterprise and government contracts (e.g., Tennessee DIDD two-year pilot); and CPT III Code 0770T for clinical VR therapy billing. Distribution runs through direct enterprise sales, the floreovr.com storefront, the Meta Quest Store, and the PICO Business Store. To date, Floreo has raised approximately $12.1M in venture funding across a 2017 seed, an October 2022 $10M Series A led by Tenfore Holdings, and a small July 2025 round; Cleveland Clinic joined as a strategic investor and board observer in April 2024.

Floreo firmographics

Firmographics
Name
Floreo
Legal name
Floreo, Inc.
Website
https://floreovr.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Floreo develops FDA-designated virtual reality therapy software that delivers immersive social, communication, and behavioral skills training to neurodiverse individuals (autism, ADHD, anxiety), serving healthcare providers, K-12 schools, state disability agencies, and families via subscription, Medicaid waiver, and CPT III billing.
Ownership category
akta.pro rank

Floreo industry classification

Industry
Product category
Virtual Reality Behavioral Therapy Software
NAICS
Services for the Elderly and Persons with Disabilities (624120)
akta.pro industry
PRIMARYEDAKAHAL
Telehealth/Remote ABA & Digital Behavior Coaching
Education/Special Education & Learning Support Services/Behavioral Intervention & Applied Behavior Analysis (ABA)

Keywords

  • Virtual reality therapy
  • Autism behavioral therapy
  • Digital therapeutics
  • Neurodiverse skill training
  • Social skills VR platform

Where Floreo is headquartered

Location

Headquarters

HQ city
Chevy Chase
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Floreo business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Subscription Licensing: Recurring subscription model for access to VR lesson library and platform features. Subscriptions available for families, schools, and enterprise/organizational accounts. Pricing varies by account type and user count.
  2. State Waiver Reimbursement: Floreo subscriptions eligible for reimbursement through state Medicaid waiver programs including Wisconsin (Children's Long Term Support waiver), Tennessee (MAPS program), New York (OPWDD Self Directed Services Waiver), Maryland, and Washington DC. Equipment rental also covered under some waivers.
  3. Equipment Rental: VR headset rental bundled with subscriptions for families, particularly through state waiver programs. Provides complete solution including hardware and software.
  4. CPT III Code 0770T: Floreo sponsored the application for CPT III Code 0770T representing practice expense for VR technology software, enabling clinics to report VR technology use per session for therapy billing.
  5. Enterprise/Government Contracts: Direct contracts with state government agencies (Tennessee DIDD), county boards of developmental disabilities, and school districts for deployment of VR therapy programs.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise/organizational subscription for providers, schools, and institutions
SubscriptionAnnualFloreo Classroom Bundle for schools
SubscriptionMonthlyFamily/home subscription
Unit PricingMonthlyEquipment rental with subscription

Go-to-market motion4 records

Distribution channels6 records

Marketing channels6 records

Floreo product offering

Product offering

Core offering

Floreo provides a research-based virtual reality behavioral therapy platform that enables neurodiverse individuals (primarily those with autism, ADHD, and anxiety) to practice social, communication, behavioral regulation, daily living, and independent living skills through immersive VR simulations. The platform is offered as audience-tailored subscriptions: Floreo for Providers (clinics and therapy practices), Floreo for Education (K-12 schools and districts), and Floreo for Families (home use), with optional bundled VR headset rental and telehealth-ready remote delivery. A separate regulated product, FloreoRx, is pursuing FDA De Novo authorization as a therapeutic device for ASD social communication skills.

Product overview

Floreo is a virtual reality behavioral therapy platform consisting of a core VR software product supplemented by audience-specific modules. The core Floreo VR Platform delivers immersive social and behavioral skills training through VR simulations accessible via smartphone/Cardboard, Meta Quest, and PICO headsets. Enterprise variants include Floreo for Providers (clinics/therapists), Floreo for Education (schools), and Floreo for Families (home use). FloreoRx represents the company's FDA-regulated therapeutic device pathway targeting ASD social communication skills. The portfolio was expanded through the 2024 acquisition of Autism Eyes (autism diagnostics from Cleveland Clinic) and the Digital Boundaries content series (online safety training). The platform incorporates AI characters powered by OpenAI for interactive conversational experiences.

Differentiator

Problem solved

Functional benefit

Products and services

  • Floreo for Providers Enterprise VR subscription for healthcare providers (clinics, therapy practices, ABA therapy organizations) enabling clinicians to deliver VR-based behavioral therapy sessions with progress tracking, reporting, telehealth-ready delivery, and support for CPT III Code 0770T billing.
  • Floreo for Education K-12 education subscription enabling schools, charter schools, and districts to use Floreo VR lessons for social skills instruction, classroom accommodations, special education programming, executive functioning skill development, and transition planning, with FERPA-compliant school official framework.
  • Floreo for Families Direct-to-consumer monthly home subscription for parents and caregivers of neurodiverse children and adults, enabling home-based VR therapy practice, skill reinforcement, and family coaching with COPPA compliance and optional Meta Quest headset rental.
  • FloreoRx FDA-regulated VR-based therapeutic software (De Novo pending) designed to support skill development in individuals with Autism Spectrum Disorder; if authorized, would be one of the first FDA-authorized therapeutic devices for core social communication challenges associated with ASD.
  • Digital Boundaries Series of VR simulations focused on online safety skills for neurodivergent youth and adults, developed in partnership with Cuyahoga County Board of Developmental Disabilities and designed to be rolled out across Cleveland and nationwide.
  • Autism Eyes Acquired autism diagnostics product from Cleveland Clinic Innovations providing accelerated and objective assessment of autism risk to streamline diagnosis and potentially improve patient outcomes; expanded Floreo into the autism diagnostics space.

Quantifiable outcome

  • 45.6% responder rate vs 23.3% VR control in pivotal trial; 95.1% skill mastery rate; sustained improvements at 60-day follow-up; no serious adverse events

Companies that use Floreo

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Floreo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature6 records

Floreo partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Cuyahoga County Board of Developmental DisabilitiescoreStrategic or Co-development Partner · 16 October 2025Partnership to create Digital Boundaries online safety training program for neurodivergent youth and adults, to be rolled out across Cleveland and nationwide.
  • Cleveland Clinic Innovations / Autism EyescoreStrategic or Co-development Partner · 4 April 2024Acquired Autism Eyes, a Cleveland Clinic Innovations portfolio company focused on autism diagnostics, expanding Floreo into diagnostics space. Cleveland Clinic also made a strategic investment in Floreo and joined its board as an observer.
  • PICO Business Store (ByteDance)coreTechnology or Integration · 21 March 2024Floreo available in PICO Business Store for enterprise PICO headset users (Neo3, Neo3 Pro/Pro Eye, PICO 4E, PICO 4 Ultra).
  • Tennessee Department of Intellectual and Developmental DisabilitiescoreStrategic or Co-development Partner · 16 March 2022Two-year contract for VR pilot project developing transportation and job skills curriculum for people with intellectual and developmental disabilities.
  • Cortica HealthcarecoreStrategic or Co-development PartnerConducted pivotal clinical trial for FloreoRx FDA submission across 18 clinical sites with 125 enrolled patients demonstrating statistically significant improvements.
  • Meta (Meta Quest)coreTechnology or IntegrationCollaboration with Meta for Immersive Learning Program providing free Meta Quest 2 headsets to schools; Floreo available on Meta Quest store.
  • Easterseals FloridaminorStrategic or Co-development PartnerWorkforce development program using Floreo with neurodiverse students; Easterseals received Meta Quest headsets through Immersive Learning Program.
  • The School District of Palm Beach CountyminorStrategic or Co-development PartnerFlorida school district signed up to implement Floreo program for neurodiverse students.
  • Wattle Supports PTY LTDminorChannel Partner/ Reseller/ DistributorAustralia-based partner signed up to begin Floreo program serving neurodiverse clients and community.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

Floreo competitors and assessment

Company assessment

Direct peers

  • AppliedVR: AppliedVR develops FDA-authorized VR therapeutic software (EaseVRx for chronic pain) and is expanding into mental health and behavioral indications. Like Floreo, it pursues the FDA digital therapeutics regulatory pathway and distributes via consumer VR hardware, making it a closely comparable regulatory and commercial peer.
  • XRHealth: XRHealth operates a VR-based telehealth platform delivering clinician-supervised therapeutic experiences across mental health, neurological, and physical conditions. It directly parallels Floreo's VR telehealth delivery model, multi-condition content library, and provider/clinic GTM motion.
  • BehaVR: BehaVR builds immersive VR therapeutics for mental health (anxiety, depression, chronic pain) and partners with payers and providers on prescription digital therapeutics. Like Floreo, it combines clinical evidence generation with multi-headset distribution and a regulatory-grade development approach.
  • PresenceLearning: PresenceLearning provides live, online tele-ABA and related special education services to schools and districts nationwide. It overlaps directly with Floreo's behavioral intervention + telehealth delivery focus on the school-district and provider buyer, addressing a similar neurodiverse learner base.

Broad incumbents

  • CentralReach: CentralReach is an established practice management and clinical platform serving ABA and behavioral health providers at scale. It represents the incumbent software stack that Floreo providers may already use, making it a competitor for clinician wallet share and a potential integration or competitive threat to Floreo's clinical workflow layer.
  • Rethink Behavioral Health: Rethink provides digital tools, training, and consulting for ABA providers, educators, and employers serving individuals with autism and IDD. It is a broader incumbent in the same behavioral intervention space Floreo targets, with overlapping school and provider buyers.

Emerging players

  • Cognivive: Cognivive develops VR-based cognitive and behavioral therapy experiences, including attention and executive function training. It is an emerging peer focused on a narrower cognitive therapy niche within the same VR-based behavioral intervention category Floreo occupies.
  • Limbic: Limbic builds AI-driven mental health support tools (including AI therapy companions) used by healthcare providers. While not VR-based, its focus on AI-augmented behavioral therapy delivery for clinical populations makes it thematically comparable to Floreo's generative AI character work in VR lessons.

Others

  • HopSkipDrive: HopSkipDrive is a specialized ride service for vulnerable populations including children with special needs, frequently reimbursed through Medicaid waivers in multiple states. It is a relevant peer in the special-needs Medicaid waiver ecosystem where Floreo also distributes subscriptions to families.
  • Cleveland Clinic Innovations: Cleveland Clinic Innovations is the corporate venture arm of Cleveland Clinic and was a prior owner of Autism Eyes, now acquired by Floreo. Cleveland Clinic also made a strategic investment in Floreo and holds a board observer seat — making it both a transaction counterparty and a strategic backer in the neurodiverse care space Floreo operates in.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Floreo social profiles

Digital presence

Floreo compliance and trust

Trust signal

Compliance4 records

Floreo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Floreo leadership team

Management profile

Number of profiles

Profiles8 records

Floreo subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Floreo funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Floreo M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Floreo

What does Floreo do?

Floreo provides a research-based virtual reality behavioral therapy platform that enables neurodiverse individuals (primarily those with autism, ADHD, and anxiety) to practice social, communication, behavioral regulation, daily living, and independent living skills through immersive VR simulations. The platform is offered as audience-tailored subscriptions: Floreo for Providers (clinics and therapy practices), Floreo for Education (K-12 schools and districts), and Floreo for Families (home use), with optional bundled VR headset rental and telehealth-ready remote delivery. A separate regulated product, FloreoRx, is pursuing FDA De Novo authorization as a therapeutic device for ASD social communication skills.

Is Floreo a public or private company?

Floreo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Floreo founded?

Floreo was founded in 2016. It employs 51 to 100 people.

Where is Floreo based?

Floreo is headquartered in Chevy Chase, United States, in the North America region.

How does Floreo make money?

Five revenue lines are on record. Subscription Licensing is the primary driver. The others are state Waiver Reimbursement, equipment Rental, CPT III Code 0770T and enterprise/Government Contracts.

Who are Floreo's main competitors?

Direct peers on record are AppliedVR, XRHealth, BehaVR and PresenceLearning. Broad incumbents are CentralReach and Rethink Behavioral Health. Emerging players are Cognivive and Limbic. Others are HopSkipDrive and Cleveland Clinic Innovations.

Does Floreo have an API?

No public API is recorded for Floreo.

What industry is Floreo in?

Floreo's product category is Virtual Reality Behavioral Therapy Software. Its primary akta.pro industry code is EDAKAHAL, Telehealth/Remote ABA & Digital Behavior Coaching. Its NAICS code is 624120.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNorth Carolina Approves Reimbursement of VR Therapy for Neurodivergent Residents Under NC Innovations WaiverNorth Carolina approved Medicaid waiver reimbursement for Floreo's virtual reality therapy for neurodivergent youth and adults under the NC Innovations Waiver. The approval covers seven counties managed by Alliance Health, and families can request reimbursement through their care manager. Floreo is the first VR autism technology to receive FDA breakthrough device designation.AL.comAlabama family says virtual reality program helps people with autism: ‘Encouraging’Floreo, a company developing virtual reality programs for individuals with autism, is seeking FDA approval for its investigational device FloreoRX following positive clinical trial results. The article highlights the company's efforts to provide science-backed interventions that help users build social and life skills, while also noting challenges families face in accessing such services through state Medicaid waivers.News-MedicalAutistic people gain measurable police-interaction skills after short VR trainingA randomized controlled trial found that a short VR-based training program reduced fidgeting and improved verbal responses in autistic participants during police interactions. The study included 47 participants aged 12-60, with VR outperforming video-based education. Researchers suggest VR offers repeatable, realistic practice for high-pressure encounters.AijournFollowing Pivotal Trial, FDA Set to Review First-of-a-Kind VR Autism TherapyFloreo announced the submission of a De Novo request to the FDA for FloreoRx, its VR-based therapeutic software designed to support skill development in individuals with Autism Spectrum Disorder, following a pivotal trial that demonstrated statistically significant improvements over a VR control group (45.6% vs 23.3% responder rates). The trial, conducted in partnership with Cortica Healthcare across 18 clinical sites with 125 enrolled patients, showed that participants receiving Floreo treatment achieved clinically meaningful outcomes including sustained improvements at 60-day follow-up and a 95.1% skill mastery rate, with no serious adverse events reported. If authorized, FloreoRx could become one of the first FDA-authorized therapeutic devices specifically intended to address core social communication challenges associated with Autism Spectrum Disorder.PR NewswireFollowing Pivotal Trial, FDA Set to Review First-of-a-Kind VR Autism TherapyFloreo announced the submission of a De Novo request to the FDA for FloreoRx, its investigational VR-based software product designed to support skill development in individuals with Autism Spectrum Disorder. The submission is supported by data from a pivotal trial conducted in partnership with Cortica Healthcare across 18 clinical sites, which demonstrated statistically significant results with participants in the Floreo group showing higher responder rates (45.6%) compared to the VR control group (23.3%). If authorized, FloreoRx could become one of the first FDA-authorized therapeutic devices intended to address core social communication challenges associated with Autism Spectrum Disorder.Nashville SceneVirtual Reality Therapy Gives Neurodivergent People a Practice RunTennessee has become one of the first states to cover Floreo's virtual reality therapy product through its Medicaid Enabling Technology program for people with disabilities. The technology, developed by Floreo, allows neurodivergent individuals to practice everyday tasks in a low-risk environment, with reported success rates showing that approximately 80% of students can apply learned skills to real-world scenarios.PR NewswireOhio County Board of Development Disabilities Teams Up with VR Developer to Create Online Safety Training for Neurodivergent Youth and AdultsFloreo released a new VR simulation series called Digital Boundaries in partnership with Cuyahoga County Board of Developmental Disabilities to help individuals with autism and other developmental disabilities safely navigate online interactions. Research cited in the article shows neurodivergent youth are twice as likely to be victims of cyberbullying and less likely to block unsafe content or individuals compared to their peers. The module, piloted with Cuyahoga DD participants, will be rolled out this fall through Cuyahoga DD's assistive technology team and made available nationwide through Floreo.ChalkbeatThis NYC autism schools uses VR for social skills trainingThe New York City Autism Charter School in the South Bronx uses a virtual reality program called Floreo to help students with autism develop social skills such as raising hands, taking turns, and making friends. The VR tool allows teachers to work individually with students while simulating real-world social scenarios in a low-stakes environment where mistakes carry no social consequences. More than 100 schools and therapy offices in the U.S. currently use Floreo, though widespread adoption faces challenges including equipment costs and limited insurance coverage.PR NewswireTennessee Expands Access to Virtual Reality-Based Therapy for Neurodivergent Tennesseans on MedicaidThe Tennessee Department of Disability & Aging has approved Medicaid reimbursement for Floreo's virtual reality-based therapy services for neurodivergent youth and adults supported by TennCare. With this statewide credential, Floreo is now authorized to deliver services through all three of Tennessee's Medicaid managed care organizations: Wellpoint, BlueCare, and UnitedHealthcare. The VR therapy platform, which received FDA breakthrough device designation in 2023, helps users develop social, behavioral, and daily life skills through immersive real-world scenario practice.AdvancedautismVirtual Reality in Autism TherapyVirtual reality (VR) therapy has emerged as a scientifically supported approach for autism spectrum disorder (ASD) treatment, offering immersive environments where individuals can safely practice social, emotional, and daily living skills. A meta-analysis of 33 studies reported an overall effect size of g=0.74, with particularly strong results for daily living skills (g=1.15) and moderate improvements in social and communication skills (g=0.69). Specialized platforms such as Floreo VR (which has received FDA breakthrough device designation) and XRHealth provide tailored therapeutic applications for neurodiverse individuals, using devices like Oculus Quest and PICO headsets.